NRC HEALTH (NRC) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000070487 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $35.4M | $-3.3M | $-0.15 | Filing |
| Mar 31, 2026 | Apr 28, 2026 | $34.8M | $3.2M | $0.14 | Filing |
| Dec 31, 2025 | Feb 3, 2026 | $35.2M | — | $49.58 | Filing |
| Sep 30, 2025 | Oct 27, 2025 | $34.6M | — | $0.18 | Filing |
| Jun 30, 2025 | Jul 28, 2025 | $34.0M | $-106,000 | $-0.01 | Filing |
| Mar 31, 2025 | Apr 28, 2025 | $33.6M | $5.8M | $0.25 | Filing |
| Dec 31, 2024 | Jan 27, 2025 | $36.9M | — | $0.27 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $35.8M | — | $0.24 | Filing |
What would NRC HEALTH have to report for its valuation to change?
At $21.11, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -48.5% a year, to $1.80. On that path the next quarter needs diluted EPS near $0.09, against $0.18 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -48.5% | -48.5% |
| EPS needed in final year | $1.80 | $1.80 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. NRC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.